2 The Health Canada approval of Trulicity is based on data from the AWARD clinical trial program, designed to evaluate the safety and efficacy of dulaglutide in adults with type 2 diabetes
It maps your complete hormonal landscape including cortisol patterns, thyroid metabolites, DHEA, testosterone, estrogen metabolites, and melatonin
The most common form of MCTs produced through the interesterification process of glycerol and C6:0, C8:0, C10:0, and C12:0 derived from coconut oil is Captrin
The NADH and FADH 2 generated during the fat oxidation and acetyl-CoA oxidation in the TCA cycle then can enter the respiratory pathway for the production of ATP via oxidative phosphorylation (Chapter 14)
GLP-1 receptor agonists are licensed in the UK for type 2 diabetes and weight management, including semaglutide, dulaglutide, and liraglutide These medications reduce HbA1c by approximately 1.01.5 percentage points and improve both fasting and post-meal glucose levels Weight loss associated with GLP-1 therapy can lead to secondary improvements in insulin resistance, particularly through reduction of visceral fat Common side effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhoea, which typically diminish over several weeks NICE recommends continuation only if patients achieve at least 1.0 percentage point HbA1c reduction within six months of treatment initiation Patients with diabetic retinopathy require close monitoring, and GLP-1 medications should be discontinued at least two months before planned pregnancy Table of Contents What Are GLP-1 Receptor Agonists and How Do They Work
